Southern Company (The) 2025 Series A Corporate Units (SOMN)

Total Current Assets

$12.38B

Quarterly · Period ending: · USD

SOMN logo

SOMN Total Current Assets

Latest reported$12.38B
SOMN Quarterly Current Assets ($2.85B → $12.38B)
High-resolution chart · PNG

SOMN total current assets history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Southern Company (The) 2025 Series A Corporate Units Total Current Assets — Quarterly (USD)
Period endingTotal Current Assets (USD)
12,378,000,000
9,961,000,000
10,917,000,000
12,627,000,000
10,801,000,000
11,817,000,000
10,694,000,000
11,040,000,000
10,993,000,000
10,543,000,000
10,432,000,000
11,088,000,000
10,979,000,000
9,555,000,000
10,416,000,000
10,363,000,000
9,781,000,000
9,297,000,000
8,965,000,000
9,674,000,000
9,551,000,000
9,469,000,000
8,617,000,000
10,574,000,000
9,069,000,000
9,430,000,000
9,817,000,000
9,917,000,000
8,352,000,000
8,709,000,000
9,583,000,000
9,384,000,000
11,619,000,000
9,524,000,000
10,072,000,000
9,202,000,000
8,837,000,000
8,427,000,000
9,722,000,000
9,658,000,000
15,149,000,000
5,461,000,000
6,526,000,000
6,270,000,000
6,605,000,000
6,372,000,000
5,864,000,000
6,258,000,000
5,376,000,000
5,140,000,000
5,614,000,000
5,785,000,000
6,001,000,000
5,932,000,000
6,162,000,000
6,696,000,000
6,373,000,000
6,041,000,000
6,272,000,000
6,495,000,000
5,502,000,000
5,240,000,000
5,883,000,000
6,609,000,000
5,524,000,000
5,220,131,000
5,873,000,000
5,881,933,000
6,389,370,000
5,948,748,000
5,358,000,000
5,824,701,000
5,368,616,000
4,826,000,000
4,732,000,000
5,435,854,000
4,754,108,000
4,024,338,000
4,019,000,000
4,782,538,000
4,320,382,000
4,212,016,000
4,205,000,000
4,452,188,000
3,585,997,000
3,600,148,000
3,491,000,000
3,372,160,000
3,168,487,000
2,894,861,000
3,060,000,000
3,420,958,000
2,958,295,000
2,921,616,000
2,929,000,000
3,132,781,000
3,344,629,000
2,750,176,000
2,956,000,000
3,273,252,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.